Supply interruption risk from concentration of manufacturing sites
First written in FY2016. 5 of 7 entries say "Mitigated", first in FY2020. Latest entry: FY2026.
Nippon Shinyaku moved to the "Worse" side of this theme in 2026, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 6 of 19 companies on the "Worse" side.
0 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「An analysis found that the Odawara General Pharmaceutical Plant would not suffer a financial impact if a climate-related disaster occurred and operations were suspended, because it holds approximately 6.3 months of inventory.」
The analysis of inventory holdings during a disaster changed from approximately 7.3 months to approximately 6.3 months, indicating a smaller inventory buffer against supply interruptions. - FY2025MitigatedAnnual report
「An analysis found that the Odawara General Pharmaceutical Plant would not suffer a financial impact if a climate-related disaster occurred and operations were suspended, because it holds approximately 7.3 months of inventory.」
The disclosure presents the results of an analysis of the financial impact of supply interruptions during a disaster based on holding approximately 7.3 months of inventory. - FY2024MitigatedAnnual report
「At the Odawara General Pharmaceutical Plant, the Group's pharmaceutical production site, a business continuity plan (BCP) has been developed based on a scenario assuming an earthquake with a seismic intensity of 6 upper. The plant has also established countermeasure manuals for storm and flood damage and a Mount Fuji eruption. In addition, it is working to establish systems that enable a stable supply of pharmaceuticals even in an emergency, including securing safety stock and creating a framework for sharing information with suppliers.」
In response to the risk of manufacturing-site shutdowns, the company has established BCPs and countermeasure manuals covering seismic intensity 6 upper earthquakes, storm and flood damage and a Mount Fuji eruption, as well as safety stock and supplier information-sharing systems. - FY2023MitigatedAnnual report
「To prepare for these and other disaster-related risks, the Group has established systems to protect employee safety and ensure a stable supply of pharmaceuticals, including the development and implementation of business continuity plans (BCPs), earthquake-resistance measures and the maintenance of safety stock, and is working to reduce risk.」
The disclosure describes a combination of BCPs, drills, earthquake-resistance measures and safety stock in response to the risk of manufacturing-site and supply shutdowns. - FY2021MitigatedAnnual report
「To prepare for risks related to disasters and other events, the Group is developing and conducting drills for business continuity plans (BCPs) at its manufacturing sites and working to maintain safety stock.」
The company reiterates its BCP drills and safety-stock measures in response to the risk of manufacturing-site and supply shutdowns. - FY2020MitigatedAnnual report
「To prepare for risks related to disasters and other events, the Group is developing and conducting drills for business continuity plans (BCPs) at its manufacturing sites and working to maintain safety stock.」
In response to the risk of supply interruptions caused by manufacturing-site shutdowns, the company is developing and conducting BCP drills and securing safety stock. - FY2016First statedAnnual report
「The Group has consolidated its manufacturing sites to improve production efficiency. Conversely, if operations at a manufacturing site are suspended due to a natural disaster or other event, product supplies could be interrupted, affecting operating results.」
The disclosure presents both the consolidation of manufacturing sites to improve production efficiency and the resulting risk of operational disruptions.